Double Potential Interval. Introduction: A corridor of double potentials along the ablation line has been recognized to be an indicator of complete cavotricuspid isthmus block. Isoproterenol is used to confirm cavotricuspid isthmus block, but the effects of isoproterenol on the double potential interval (DPI), either in the absence or presence of amiodarone, are unknown.
Introduction
A corridor of double potentials along the ablation line is recognized to be an indicator of complete block in the cavotricuspid isthmus in patients undergoing radiofrequency catheter ablation of isthmus-dependent atrial flutter. [1] [2] [3] The endpoint of complete isthmus block is more reliable when confirmed during infusion of isoproterenol. 4 However, no prior studies have determined the effects of isoproterenol on double potentials along an ablation line in the cavotricuspid isthmus. Furthermore, although catheter ablation procedures usually are performed in the drug-free state, this often is not feasible in patients treated with amiodarone because of its long elimination half-life. 5 The interaction between isoproterenol and amiodarone after complete block in the cavotricuspid isthmus also has not been determined. Therefore, the aim of this study was to examine the effects of isoproterenol on the double potential interval after the creation of cavotricuspid isthmus block, both in the absence and presence of amiodarone.
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Methods

Characteristics of Subjects
The subjects of this study were 32 patients (23 men and 9 women; mean age 59 ± 14 years [±SD]) who underwent radiofrequency catheter ablation of isthmus-dependent atrial flutter at the University of Michigan Medical Center. Structural heart disease was present in 9 patients (28%): coronary artery disease in 4, nonischemic cardiomyopathy in 2, and hypertensive heart disease in 3. Treatment with all antiarrhythmic medications was discontinued for at least five half-lives in 23 patients who had not been treated with amiodarone. In 9 patients who had been treated with amiodarone for at least 6 months, amiodarone was withheld for 2 to 7 days before the ablation procedure. The dosage of amiodarone was 200 mg/day in all of the patients who had been treated with amiodarone.
Catheter Ablation Procedure
All patients provided informed consent before the electrophysiologic procedure. A 7-French duodecapolar halo catheter (2-mm spacing between electrodes of each bipole; spacing between pairs of electrodes = 20-2-2-2-2-2-2-25-25-25 mm, Daig Corporation, Minnetonka, MN, USA) was positioned along the tricuspid annulus with the distal bipole of the halo catheter within the proximal portion of the coronary sinus. A 7-French quadripolar catheter (EP Technologies, San Jose, CA, USA) was positioned within the proximal coronary sinus for pacing. A 7-French quadripolar catheter with a deflectable tip, 4-mm distal electrode (2-5-2 mm interelectrode spacing), and a thermistor embedded in the distal electrode (EP Technologies) was used for mapping the isthmus and delivering radiofrequency energy.
Bipolar electrograms were filtered at settings of 30 to 500 Hz and recorded digitally (EPMed Systems, Mount Arlington, NJ, USA). Electrograms were analyzed offline at a gain setting of 0.1 to 0.2 mV/cm and at a sweep speed of 100 to 200 mm/sec. Coronary sinus pacing was performed with a stimulator (model EP-3 clinical stimulator, EPMed Systems) at twice diastolic threshold and with a pulse width of 2 msec.
Under fluoroscopic guidance, contiguous applications of radiofrequency energy were delivered to create a line of block in the cavotricuspid isthmus. The power was automatically adjusted to maintain a target temperature of 60
• C at the electrode-tissue interface. Each application of energy was 45 to 60 seconds in duration.
The endpoint of the procedure was complete isthmus block in the clockwise and counterclockwise directions. This endpoint was attained in all patients in this study. The criteria for complete block were assessed during coronary sinus pacing at a cycle length of 600 msec and consisted of an appropriate atrial activation sequence recorded with the halo catheter, 6 negative initial polarity of the bipolar electrograms recorded just lateral to the ablation line during coronary sinus pacing, 7 and double potentials with a double potential interval >110 msec along the entire ablation line, or with an isoelectric double potential interval >90 msec. 3 Because of a history of atrial fibrillation, 3 patients were treated with amiodarone and 3 patients were treated with propafenone after flutter ablation. During a mean follow-up of 13 ± 6 months, none of the patients in this study had a recurrence of atrial flutter.
Study Protocol
After complete cavotricuspid isthmus block was achieved, the ablation catheter was positioned at a site along the ablation line at which a double potential was readily seen. Coronary sinus pacing was performed at cycle lengths of 500, 400, and 350 msec before and during infusion of 2 to 8 µg/min of isoproterenol, titrated to shorten the sinus cycle length by 30% to 35%.
The double potential interval was defined as the interval separating the two components of a double potential (Fig. 1) . The double potential interval was measured with electronic calipers from the peak of the first component of the double potential to the peak of the second component, as previously described. 3 Three double potential intervals were measured and averaged for each measurement.
Statistical Analysis
Continuous variables are expressed as mean ± 1 SD. Double potential intervals were compared using Student's t-test, paired t-test, or analysis of variance with repeated measures, as appropriate. P < 0.05 was considered statistically significant.
Results
Double Potential Intervals in the Absence of Amiodarone
Mean double potential interval at a pacing cycle length of 500 msec in the patients not treated with amiodarone was 119 ± 19 msec. Double potential interval did not change significantly during pacing at cycle lengths of 400 and 350 msec ( Figs. 1 and 2 ).
During infusion of isoproterenol, mean sinus cycle length shortened from 908 ± 157 msec to 633 ± 94 msec (P < 0.001). Mean double potential interval at a pacing cycle length of 500 msec during isoproterenol infusion shortened from 119 ± 19 msec to 111 ± 17 msec (P < 0.01, Figs. 1  and 2 ). Mean double potential interval at pacing cycle lengths of 400 and 350 msec also were significantly shorter during than before infusion of isoproterenol (P < 0.01, Fig. 2 ).
Double Potential Intervals in the Presence of Amiodarone
Mean double potential interval at a pacing cycle length of 500 msec in the patients treated with amiodarone was 147 ± 32 msec, which was significantly longer than the corresponding double potential interval in the patients not treated with amiodarone (P < 0.001, Fig. 3 ). Double potential interval lengthened significantly as the pacing cycle length shortened to 350 msec, and double potential intervals at pacing cycle lengths of 400 and 350 msec also were significantly longer than the corresponding double potential intervals in the patients who were in the drug-free state (P < 0.001, Figs. 3  and 4) .
During infusion of isoproterenol, mean sinus cycle length shortened from 1050 ± 221 msec to 681 ± 77 msec in the patients treated with amiodarone (P < 0.001). Among the patients treated with amiodarone, mean double potential interval at a pacing cycle length of 500 msec shortened significantly during infusion of isoproterenol to 134 ± 26 msec (P < 0.05, Figs. 4 and 5) . Mean double potential interval at pacing cycle lengths of 400 and 350 msec also was significantly shorter during than before infusion of isoproterenol (P < 0.01, Fig. 5 ). 
Discussion
Main Findings
The results of this study demonstrate that amiodarone lengthens the double potential interval that is recorded in the cavotricuspid isthmus after complete isthmus block is achieved by radiofrequency catheter ablation. Double potential intervals were 19% to 29% longer among patients treated with amiodarone, depending on the pacing cycle length. Furthermore, whereas isoproterenol shortened the double potential interval by only 5% to 7% in patients who were in the drug-free state, it had a more pronounced effect in patients who were treated with amiodarone. Depending on the pacing cycle length, the double potential interval shortened by 9% to 12% during infusion of isoproterenol among patients treated with amiodarone.
Double Potential Intervals as an Indicator of Complete Isthmus Block
A prior study demonstrated that a parallel corridor of double potentials separated by at least 110 msec or by an isoelectric interval of at least 90 msec along an ablation line during coronary sinus pacing is a reliable indicator of complete block in the cavotricuspid isthmus. 3 However, in that study, all patients were in the drug-free state. Amiodarone is often used to treat atrial flutter, and because of its prolonged elimination half-life, 5 it is not practical to wait for complete drug washout before performing radiofrequency catheter ablation in patients who have been drug refractory. The results of this study demonstrate that amiodarone significantly lengthens the double potential interval measured in the cavotricuspid isthmus during coronary sinus pacing.
Of note is that the data in this study were obtained only after complete isthmus block had been achieved, and complete block was confirmed by an appropriate atrial activation sequence and by changes in electrogram polarity during coronary sinus pacing. Because the double potential interval after block was achieved was lengthened by amiodarone, it is likely that amiodarone also lengthened the double potential interval when isthmus block was still incomplete. Therefore, the findings of this study imply that the double potential interval criteria of β ≤ 90 to 110 msec that are indicative of complete isthmus block are not applicable to patients who have recently been treated with amiodarone.
Response to Isoproterenol
Isoproterenol has been used to detect incomplete isthmus block in patients undergoing catheter ablation of the cavotricuspid isthmus. 4 Among patients in this study who were in the drug-free state, isoproterenol had a minimal effect on the double potential intervals along the ablation line after complete isthmus block had been achieved. Before infusion of isoproterenol, the minimum isoelectric double potential interval during coronary sinus pacing at a cycle length of 500 msec was 90 msec, and the minimum nonisoelectric double potential interval was 110 msec. When isoproterenol was infused, the minimum isopotential double potential interval shortened to 88 msec, and the minimum nonisoelectric double potential interval shortened to 104 msec. Therefore, the double potential interval criteria for complete isthmus block should be shortened by approximately 5 msec when isoproterenol is infused.
The effect of isoproterenol on the double potential interval was augmented among the patients in this study who were treated with amiodarone. Despite shortening of the double potential interval by as much as 75 msec, all patients still had evidence of complete isthmus block based on criteria that were independent of the double potential interval. Therefore, a marked shortening of the double potential interval does not necessarily indicate incomplete isthmus block among patients who have been treated with amiodarone.
Sympathetic activation by isoproterenol or epinephrine has been demonstrated to reverse the pharmacologic effects of several antiarrhythmic drugs, including verapamil, quinidine, procainamide, and flecainide. [8] [9] [10] [11] [12] [13] Because amiodarone is a β-adrenergic antagonist, 14 its electrophysiologic effects in the ventricle have been found to be more resistant to sympathetic activation than the effects of other drugs. 15, 16 Nevertheless, amiodarone's effects on ventricular conduction and refractoriness are partially attenuated by isoproterenol or epinephrine. 15, 16 The results of the present study demonstrate that amiodarone's effect on atrial conduction also is partially reversed by isoproterenol.
Decremental Conduction in the Isthmus
A prior study demonstrated that conduction across the cavotricuspid isthmus is not decremental. 17 In the present study, in drug-free patients, the double potential interval after complete cavotricuspid isthmus block was achieved was found to be stable during incremental coronary sinus pacing, consistent with an absence of decremental conduction in the cavotricuspid isthmus and in the atrial tissue surrounding the tricuspid annulus. However, the lengthening of the double potential interval during incremental coronary sinus pacing in patients treated with amiodarone indicates that this drug induced decremental conduction in the cavotricuspid isthmus and/or other areas in the right atrium. This effect of amiodarone is attributable to frequency-dependent blockade of sodium channels. 18 
Study Limitations
The effect of amiodarone on the double potential interval was assessed only after complete isthmus block was achieved. Therefore, this study does not provide information on the value of the double potential interval for discriminating incomplete from complete isthmus block in patients recently treated with amiodarone.
Conclusion
When isoproterenol is used to confirm complete block in the cavotricuspid isthmus, the double potential interval criteria of 90 to 110 msec should be adjusted downward by approximately 5 msec. However, if the patient has been recently treated with amiodarone, the double potential interval during isoproterenol infusion may shorten by as much as 75 msec despite the presence of complete cavotricuspid isthmus block. Therefore, when atrial flutter ablation is performed in the presence of amiodarone, criteria for isthmus block that are not influenced by isoproterenol, namely, the atrial activation sequence 6 and electrogram polarity, 7 may be more reliable than the double potential interval.
